Pro Share Advisors LLC Travere Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 18,451 shares of TVTX stock, worth $320,862. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,451

Previous 14,457 27.63%

Holding current value

$320,862

Previous $118,000 118.64%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$7.89 - $15.21 $31,512 - $60,748	3,994 Added 27.63%	18,451 $258,000
Q2 2024 Aug 13, 2024	SELL	$5.26 - $8.28 $20,850 - $32,821	-3,964 Reduced 21.52%	14,457 $118,000
Q1 2024 May 08, 2024	BUY	$7.18 - $9.82 $11,179 - $15,289	1,557 Added 9.23%	18,421 $142,000
Q4 2023 Feb 14, 2024	BUY	$5.44 - $9.5 $13,583 - $23,721	2,497 Added 17.38%	16,864 $151,000
Q3 2023 Nov 13, 2023	BUY	$7.64 - $17.25 $504 - $1,138	66 Added 0.46%	14,367 $128,000
Q2 2023 Aug 10, 2023	BUY	$15.3 - $22.61 $39,321 - $58,107	2,570 Added 21.91%	14,301 $219,000
Q1 2023 May 11, 2023	SELL	$17.82 - $22.89 $26,640 - $34,220	-1,495 Reduced 11.3%	11,731 $263,000
Q4 2022 Feb 02, 2023	BUY	$18.47 - $26.14 $20,908 - $29,590	1,132 Added 9.36%	13,226 $278,000
Q3 2022 Nov 04, 2022	BUY	$22.91 - $28.63 $7,010 - $8,760	306 Added 2.6%	12,094 $298,000
Q2 2022 Aug 01, 2022	SELL	$20.94 - $30.01 $122,373 - $175,378	-5,844 Reduced 33.14%	11,788 $285,000
Q1 2022 May 10, 2022	SELL	$23.61 - $30.6 $91,866 - $119,064	-3,891 Reduced 18.08%	17,632 $454,000
Q4 2021 Feb 08, 2022	BUY	$24.34 - $31.17 $26,408 - $33,819	1,085 Added 5.31%	21,523 $669,000
Q3 2021 Nov 12, 2021	SELL	$12.98 - $25.03 $72,026 - $138,891	-5,549 Reduced 21.35%	20,438 $496,000
Q2 2021 Aug 13, 2021	BUY	$14.11 - $26.4 $45,589 - $85,298	3,231 Added 14.2%	25,987 $379,000
Q1 2021 May 14, 2021	BUY	$23.37 - $31.77 $94,368 - $128,287	4,038 Added 21.57%	22,756 $568,000
Q4 2020 Feb 09, 2021	BUY	$19.17 - $27.87 $358,824 - $521,670	18,718 New	18,718 $510,000

Others Institutions Holding TVTX

# of Institutions

192

Shares Held

84.5M

Call Options Held

776K

Put Options Held

900K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.12B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Travere Therapeutics, Inc. Transaction History